Prescription Medicines:

Urch Publishing
Management Report  April 2003

Setting the right price and ensuring that the product is adequately reimbursed is vital for a company's profitability. The Pharmaceutical Pricing Compendium - A practical guide to the pricing and reimbursement of medicines provides the essential insight into the business, economic, legal, political and strategic issues that companies must consider when pricing a product.

Pricing and reimbursement is one of the most complicated and important business issues that the pharmaceuticals industry has to deal with. 

Setting the right price and ensuring that the product is adequately reimbursed is vital for a company's profitability. The Pharmaceutical Pricing Compendium - A practical guide to the pricing and reimbursement of medicines provides the essential insight into the business, economic, legal, political and strategic issues that companies must consider when pricing a product. 

This unique publication brings together articles, by some of the most qualified and distinguished commentators on pharmaceutical pricing, that deliver clear information on the practical business issues that surround the subject. Issues covered include:

 -Global pricing strategies for product launched

- An assessment of modelling & forecasting tools

- The impact of the AIDS crisis on drug prices

- The effect of drug prices on the US economy

- Differential pricing and parallel trade in Europe

Foreword

Chapter 1 The art of pricing in the pharmaceutical industry
Mario R. Nacinovich Jr, Fission Communications (US)

The Business of Pricing

Chapter 2. Global pricing strategies for pharmaceutical product launches
Peter J. Rankin, Gregory K. Bell, Tim Wilsdon, Charles River Associates (US)

Chapter 3. Integrating pricing and reimbursement needs into drug development
Cecil Nick, PAREXEL International (UK)

Marketing issues

Chapter 4. Assessing the pharmaceutical price modelling tools
Gary Johnson, Inpharmation Ltd (UK)

Chapter 5. Managing price throughout the life cycle of a pharmaceutical product: tools, timing and strategies
Judith D. Bentkover, Marc R. Larochelle; Patricia M. Russell, Innovative Health Solutions (US)

The effect of Health Economics
Chapter 6. The importance of health economics in successfully achieving a sustainable price for reimbursement.
Paul C. Langley, Ph.D., 3M Pharmaceuticals (US)

Chapter 7. Hospital negotiation - the use of health economics as a support for new product pricing.
Brian Lovatt, Vision Healthcare (UK)
Ethical vs. economic issues

Chapter 8 The global AIDS crisis and drug pricing controversy
Dr Faiz Kermani, Chiltern International (UK)

Regional Issues in Pricing and Reimbursement
Chapter 9. Trends in international pharmaceutical pricing and reimbursement

Jorge Mestre-Ferrandiz, Office of Health Economics (UK)

Chapter 10. The future of parallel trade in pharmaceuticals in Europe
Klaus Hilleke, Simon Kucher & Partners (Germany)

Europe

Chapter 11. Pricing considerations for new products in Europe
Dr. Roland Pfeiffer, Altana Pharma AG (Germany)

Chapter 12. Schering's policy of pharmaceutical price harmonisation in Europe
Michael Bohn, Schering AG (Germany)

United States
Chapter 13. Bio-pharmaceutical Prices and the Effects on the U.S. Economy
Roger A. Edwards, Haleh Armian-Hawley, Louise Firth, TIAX LLC (U.S.)

National and international law and pharma pricing
Chapter 14. What does the decision on the GlaxoSmithKline case in Spain now signify for differential pricing in Europe?
Lorna Brazell, Bird & Bird (UK)

Chapter 15. Additional information about pharmaceutical pricing and reimbursement

Terminology

For full details, please email jenniferc@cmsinfo.com

Order Form

For more information about us, visit CMSinfo.